Empowering People Hurt by Big Businesses

Local (415) 319-8833
Toll Free (855) 534-0061

Dangerous Pharmaceuticals

Recent Posts in Dangerous Pharmaceuticals Category

  • What Are the Dangers of Zofran?

    When you receive a prescription from a doctor, you likely aren’t worried about how that drug might be defective or dangerous. Unfortunately, patients prescribed Zofran discovered the drug to be both defective and dangerous for pregnant women. About Zofran Zofran is manufactured by GlaxoSmithKline and was created to relieve symptoms of nausea and vomiting. Unfortunately, the manufacturer began to ...
    Continue Reading
  • FDA Recalls Liquid Pharmaceutical Products

    Later in September of 2017, the Food and Drug Administration (FDA) announced a recall of many liquid pharmaceutical products because of possible bacterial contamination. The products made by PharmaTech LLC in Davie, Florida, included liquid stool softeners, liquid vitamin D drops, and liquid multivitamins marketed for infants and children. Earlier, there was a discovery of Burkholderia cepacia ...
    Continue Reading
  • Cantrell Recalls Drug Because of Sterility Concerns

    According to the Food and Drug Administration (FDA), Cantrell Drug Company has recalled almost 30 lots of various sterile drug products because of a concern over their actual sterility. The products were distributed across the country to various healthcare facilities from May 25 to October 31, 2016. Some of the products contained calcium chloride, fentanyl citrate, glycopyrrolate, heparin sodium, ...
    Continue Reading
  • Januvia Side Effects May Include Pancreatic Cancer

    Januvia is the marketed name of sitagliptin, an oral antihyperglycemic drug used to manage Type 2 diabetes. Januvia is a prescription drug used in incretin therapy, which signals the pancreas to create more insulin and decrease the sugar made by the liver. It was approved in 2006 and is one of the most popular Type 2 diabetes drugs on the market. However, some studies of the drug have shown rare ...
    Continue Reading
  • Invokana Lawsuits Consolidated into Multi-District Litigation

    Drug manufacturing mega-giant Johnson & Johnson has faced its fair share of lawsuits over the last several years, and one of the latest involves a class of type 2 diabetes treatment drugs known as GLT-2 inhibitors. Johnson & Johnson, along with Janssen Pharmaceuticals, Inc. produces arguably the most popular drug in this class, known as Invokana. Back in 2015, the Food and Drug Administration ...
    Continue Reading
  • EpiPen Makers Recall Products Nationwide

    Epinephrine autoinjectors, otherwise known as EpiPens, are medical devices used to inject a measured dose of epinephrine to help treat anaphylaxis. Many people depend on these devices to survive potentially life-threatening allergic responses. Just last month, Meridian Medical Technologies, a manufacturer of Mylan’s EpiPen, expanded a recent voluntary recall to include medical devices shipped to ...
    Continue Reading
  • Taxotere Hair Loss Lawsuit Filed

    Taxotere is the brand name of docetaxel, a chemotherapy medication used to treat various types of cancer, including cancer that affects the breasts, head and neck, stomach, prostate, and non small-cell lung. Like most chemotherapy drugs, it does have side effects most patients experience when injected with it, including low blood cell counts, numbness, shortness of breath, vomiting, muscle pain, ...
    Continue Reading
  • Heartburn Medication Linked to Stomach Cancer

    Heartburn medication is often used to control stomach acid and treat conditions such as heartburn, acid reflux, peptic ulcers, and other related health conditions. Millions of people nationwide use over-the-counter or prescription heartburn medication to help them reduce the most severe of symptoms of heartburn, which can be caused by certain foods, alcohol, or other related health problems. But ...
    Continue Reading
  • Chronic Heartburn Medication Can Cause Dangerous Side Effects

    Chronic heartburn is not a health condition that should be taken lightly. If unaddressed, it could cause significant damage to the stomach and esophagus, as well as lead to the development of certain cancers. Proton pump inhibitors (PPI) are drugs manufactured with the sole purpose of controlling heartburn and acid reflux disease. As useful as a PPI might be to some patients, new studies are ...
    Continue Reading
  • More Talcum Powder Lawsuits On the Horizon

    In early 2016, pharmaceutical giant Johnson & Johnson (J&J) was ordered by an Alabama court to pay $72 million in compensation to plaintiffs who claimed that a family member had died of ovarian cancer caused by her regular use of the company’s talcum powder products . A few months later, the company once again lost a similar lawsuit, which cited the same grounds, in South Dakota, resulting in a ...
    Continue Reading
  • FDA ISSUES RECALL NOTICE ABOUT MYLAN INJECTABLE PRODUCTS

    The FDA recently warned healthcare professionals of a recall of various injectable medications by Mylan N.V. These pharmaceuticals include gemcitabine, carboplatin, methotrexate, and cytarabine, which are mostly used to treat various types of cancer. Mylan has recalled certain lots of these injectable products that were distributed in 2014. The reason for the nationwide recall is "the presence of ...
    Continue Reading
  • ANTIPSYCHOTIC DRUG COULD CAUSE FATAL SKIN REACTIONS

    The FDA recently issued a safety warning about a serious condition associated with the use of the antipsychotic drug ziprasidone. Also marketed under the brand name Geodon, this drug is used to treat schizophrenia and bipolar disorder. The FDA warning cautions that taking ziprasidone could cause "a rare but serious skin reaction" known as DRESS. The condition could "start as a rash that can spread ...
    Continue Reading
  • FDA ISSUES RECALL NOTICE ABOUT CUBICIN

    The FDA recently warned healthcare professionals of a recall of Cubist Pharmaceuticals' Cubicin (daptomycin for injection). Cubicin is an intravenous antibiotic prescribed "for the treatment of skin infections and certain blood stream infections." Cubist Pharmaceuticals has recalled nine lots of Cubicin shipped between September 2013 and December 2013 due to the presence of foreign particulate ...
    Continue Reading
  • FDA WARNS AGAINST USING LIDOCAINE TO TREAT TEETHING PAIN

    The FDA recently issued a safety announcement alerting of serious risks associated with the use of lidocaine. Use of prescription oral viscous lidocaine to treat teething pain in infants and young children could result in grave harm, including death. The FDA is requiring a Boxed Warning, FDA's strongest warning, to be added to the drug label to highlight the risk of severe adverse reactions. The ...
    Continue Reading
  • WEIGHT LOSS DRUG COULD CAUSE CANCER AND CARDIAC PROBLEMS

    The FDA recently cautioned consumers not to purchase or use La Jiao Shou Shen, a product promoted as a weight loss supplement. A laboratory analysis conducted by the FDA confirmed the product contains the undeclared ingredients sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in 2010 due to safety concerns. Sibutramine can "interact, in ...
    Continue Reading
  • THE EUROPEAN MEDICINES AGENCY INITIATES REVIEW OF TESTOSTERONE PRODUCTS OVER CONCERNS ABOUT CARDIAC SIDE EFFECTS

    The European Medicines Agency (EMA) recently started a safety review of testosterone-containing products. The review was initiated at the request of the Estonian medicines agency due to concerns about harmful effects of testosterone therapy (TT) on the heart. These safety issues were raised in several recent publications that suggested significantly increased risk of heart attacks and other ...
    Continue Reading
  • HARVARD MEN'S HEALTH WATCH WARNS OF CARDIAC RISKS WITH TESTOSTERONE THERAPY

    The most recent issue of Harvard Men's Health Watch discusses the safety and risks associated with testosterone therapy (TT). The newsletter notes that millions of Americans undergo testosterone therapy, enticed by the myriad promises of lifestyle improvements offered by the "ongoing pharmaceutical marketing blitz." However, there are "legitimate safety concerns linger[ing]", such as new evidence ...
    Continue Reading
  • THE ENDOCRINE SOCIETY CALLS FOR REEVALUATION OF TESTOSTERONE THERAPY RISKS

    The Endocrine Society has issued a statement highlighting the need for robust evaluation of the risks associated with testosterone therapy (TT). In it, the Society recommends that "patients should be made aware of the potential risk of cardiovascular events in middle-aged and older men who are taking or considering testosterone therapy for age-related decline in testosterone levels and symptoms." ...
    Continue Reading
  • TESTOSTERONE STUDY OBSERVED DISCREPANCY IN RISK REPORTED BY INDUSTRY FUNDED TRIALS COMPARED TO NON-INDUSTRY FUNDED TRIALS

    A recent study published in 2013 warned that the risk of cardiovascular events is increased in men who have been prescribed testosterone therapy. Such cardiovascular events included heart attacks, congestive heart failures, coronary artery diseases, arrhythmias, and other cardiovascular disorders. In particular, this robust systematic review found the risk was increased by 54% for cardiovascular ...
    Continue Reading
  • FDA WARNS OF RECALL OF ARTIFICIAL EMBOLIZATION DEVICE

    The FDA has classified the recent device correction notice for TRUFILL n-BCA as a Class I recall. TRUFILL n-BCA is a device used for the treatment of Arterio-Venous Malformations, such as abnormal connection between the arteries and veins in the brain. It is marketed by Codman Neuro, which is part of DePuy Synthes Companies. Codman Neuro has identified an incorrect statement in the product's ...
    Continue Reading
  • FDA Requires Design Changes To Fentanyl Patches

    September 23, 2013 - As part of its efforts to regulate dangerous pharmaceuticals, the FDA issued a drug safety communication requiring changes to the design of Duragesic (fentanyl) pain patches so that the patches can be seen more easily. Fentanyl patches are dangerous and prone to cause accidental exposure because they retain potent amounts of the active narcotic ingredient even after use. ...
    Continue Reading
  • McNeil Consumer Healthcare Recalls Motrin Infants Drops Due To Contamination

    The FDA recently announced a recall initiated by McNeil Consumer Healthcare that affects three lots of MOTRIN Infant's Drops (active ingredient: ibuprofen). The recall was prompted by the presence of "tiny plastic particles" identified during manufacturing. The particles were found in a lot that was not released on the market, but was part of the same batch as the three recalled lots. The ...
    Continue Reading
  • Cubist Pharmaceuticals Recalls An Antibiotic Due To Contamination

    The FDA recently announced a recall initiated by Cubist Pharmaceuticals, Inc. that affects four lots of Cubicin (daptomycin for injection). Cubicin is an antibiotic indicated for the treatment of certain types of infections. The recall was prompted by "the presence of [glass particulates] found in a number of vials" from the four lots. No adverse reactions associated with vials containing glass ...
    Continue Reading
  • Risk Of Permanent Nerve Damage From Antibacterial Fluoroquinolone Drugs

    The FDA recently issued a safety communication requiring label changes for all antibacterial drugs that contain fluoroquinolone and are taken orally or by injection. The label updates were prompted by FDA's recent evaluation of reports from its Adverse Event Reporting System database. The evaluation demonstrated that the existing label warnings do not adequately describe "the potential rapid onset ...
    Continue Reading
  • FDA Safety Alert On Certain Baczol Antigripal And Baczol Expectorante

    The FDA recently warned that consumers should not use Baczol Antigripal and Baczol Expectorante containing sulfamethoxazole, trimethoprim, or dipirona. The drugs in question are "labeled in Spanish and marketed as antibiotics for bronchitis, pneumonia, and other respiratory infections". Sulfamethoxazole and trimethoprim can cause serious or even life-threatening conditions such as "liver failure, ...
    Continue Reading
Page 1 of 3